China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)
China flag China · Delayed Price · Currency is CNY
18.86
+0.01 (0.05%)
Mar 30, 2026, 12:14 PM CST

SHE:300294 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
573.741,3001,9611,5321,584
Short-Term Investments
108.14----
Trading Asset Securities
2,5492,1993,3623,1942,700
Cash & Short-Term Investments
3,2313,4995,3244,7264,284
Cash Growth
-7.67%-34.28%12.66%10.31%468.21%
Accounts Receivable
919.69509.38275.92567.02588.08
Other Receivables
49.1739.81264.4100.6267.9
Receivables
968.86549.19540.32667.64655.98
Inventory
996.2995.43556.94666.96676.84
Other Current Assets
37.8914.756.4313.2529.4
Total Current Assets
5,2345,0586,4286,0735,646
Property, Plant & Equipment
1,6511,170676.62722.81771.33
Long-Term Investments
356.41407.51100.39117.09144.96
Goodwill
617.5372872.61663.84663.84
Other Intangible Assets
495.56773.28269.31312.17169.47
Long-Term Deferred Tax Assets
83.2373.5447.3444.9927.44
Long-Term Deferred Charges
145.29145.988.1582.64161.62
Other Long-Term Assets
43.8444.38146.8316.2437.2
Total Assets
8,6268,4017,8298,0337,622
Accounts Payable
507.51357.62126.35303.46277.53
Accrued Expenses
421.14323.81274.14290.9261.19
Current Portion of Long-Term Debt
--0.0322.180.08
Current Portion of Leases
5.795.330.872.812.06
Current Income Taxes Payable
2.0812.448.5827.0941.45
Current Unearned Revenue
8.124.0812.2120.5812.97
Other Current Liabilities
89.1647.0934.2638.3335.66
Total Current Liabilities
1,034750.38456.45705.34630.94
Long-Term Debt
47.07-22.15-22.15
Long-Term Leases
12.737.171.410.3711.3
Long-Term Unearned Revenue
25.3919.5123.5227.0930.98
Long-Term Deferred Tax Liabilities
68136.324.565.565.94
Total Liabilities
1,187913.38508.07748.35701.3
Common Stock
504.25504.25504.25504.25511.63
Additional Paid-In Capital
4,0634,0634,0634,0654,258
Retained Earnings
2,8742,9182,7532,6162,259
Treasury Stock
-----199.96
Comprehensive Income & Other
-3.522.36---
Total Common Equity
7,4387,4877,3207,1866,829
Minority Interest
1.550.611.0799.1991.4
Shareholders' Equity
7,4397,4887,3217,2856,920
Total Liabilities & Equity
8,6268,4017,8298,0337,622
Total Debt
65.5912.5124.4535.3635.58
Net Cash (Debt)
3,1653,4865,2994,6904,248
Net Cash Growth
-9.22%-34.21%12.99%10.41%903.09%
Net Cash Per Share
6.186.9410.499.339.74
Filing Date Shares Outstanding
504.25504.25504.25504.25504.25
Total Common Shares Outstanding
504.25504.25504.25504.25504.25
Working Capital
4,2004,3085,9715,3685,015
Book Value Per Share
14.7514.8514.5214.2513.54
Tangible Book Value
6,3255,9866,9786,2105,996
Tangible Book Value Per Share
12.5411.8713.8412.3111.89
Buildings
655.73741.4527.95518.01536.62
Machinery
715.37839.25625.83671.97665.73
Construction In Progress
938.5732139.9469.3440.86
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.